Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1116129

Cover Image

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1116129

Biopolymers for Medical Applications Market Research Report by Type (Bio-BE, Bio-PC, and Bio-PET), Source, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

PUBLISHED:
PAGES: 228 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4949
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF, Excel & Online Access - 1 Year (Site License)
USD 7949
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 9949

Add to Cart

The Global Biopolymers for Medical Applications Market size was estimated at USD 1,275.87 million in 2021 and expected to reach USD 1,568.82 million in 2022, and is projected to grow at a CAGR 23.13% to reach USD 4,447.89 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Biopolymers for Medical Applications to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Bio-BE, Bio-PC, Bio-PET, Bio-PUR, Bio-degradable Starch Blends, Cellulose Derivatives, PHA, and Regenerated Cellulose.

Based on Source, the market was studied across Natural and Synthetic.

Based on Application, the market was studied across Bioresorbable Scaffolds, Drug Delivery Systems., Healing Products, Surgical Implant Devices, Wound Closure, Dentistry, and Therapeutic Imaging.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biopolymers for Medical Applications market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopolymers for Medical Applications Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopolymers for Medical Applications Market, including BASF SE, Corbion N.V., DuPont de Nemours Inc, Eastman Chemical Company, Evonik Industries, Geistlich Pharma AG, GELITA AG, HyMedPoly, INEOS Styrolution, ITV Denkendorf Product Service GmbH, NatureWorks, PSS Polymer Standards Service GmbH, Solvay, and Toray Industries Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Biopolymers for Medical Applications Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopolymers for Medical Applications Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopolymers for Medical Applications Market?
  • 4. What is the competitive strategic window for opportunities in the Global Biopolymers for Medical Applications Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Biopolymers for Medical Applications Market?
  • 6. What is the market share of the leading vendors in the Global Biopolymers for Medical Applications Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Biopolymers for Medical Applications Market?
Product Code: MRR-435FD7709B84

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand of Biopolymers for manufacturing of medical devices, replacement and implants
      • 5.1.1.2. Use of biopolymer as sensor for disease monitoring and efficient drug delivery systems
      • 5.1.1.3. Development of sterilization technology
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive development of bio-safe and non-toxic Biopolymers
    • 5.1.3. Opportunities
      • 5.1.3.1. Vertical collaboration between giants and medical industry and Plastic industry
      • 5.1.3.2. R&D investment
      • 5.1.3.3. Blending of with synthetic polymers with biopolymers to reduce the cost of the material.
    • 5.1.4. Challenges
      • 5.1.4.1. Issues with biocompatibility
  • 5.2. Cumulative Impact of COVID-19

6. Biopolymers for Medical Applications Market, by Type

  • 6.1. Introduction
  • 6.2. Bio-BE
  • 6.3. Bio-PC
  • 6.4. Bio-PET
  • 6.5. Bio-PUR
  • 6.6. Bio-degradable Starch Blends
  • 6.7. Cellulose Derivatives
  • 6.8. PHA
  • 6.9. Regenerated Cellulose

7. Biopolymers for Medical Applications Market, by Source

  • 7.1. Introduction
  • 7.2. Natural
  • 7.3. Synthetic

8. Biopolymers for Medical Applications Market, by Application

  • 8.1. Introduction
  • 8.2. Bioresorbable Scaffolds
  • 8.3. Drug Delivery Systems.
  • 8.4. Healing Products
  • 8.5. Surgical Implant Devices
  • 8.6. Wound Closure
  • 8.7. Dentistry
  • 8.8. Therapeutic Imaging

9. Americas Biopolymers for Medical Applications Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopolymers for Medical Applications Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Biopolymers for Medical Applications Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. BASF SE
  • 13.2. Corbion N.V.
  • 13.3. DuPont de Nemours Inc
  • 13.4. Eastman Chemical Company
  • 13.5. Evonik Industries
  • 13.6. Geistlich Pharma AG
  • 13.7. GELITA AG
  • 13.8. HyMedPoly
  • 13.9. INEOS Styrolution
  • 13.10. ITV Denkendorf Product Service GmbH
  • 13.11. NatureWorks
  • 13.12. PSS Polymer Standards Service GmbH
  • 13.13. Solvay
  • 13.14. Toray Industries Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
Product Code: MRR-435FD7709B84

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2021 VS 2027 (USD MILLION)
  • FIGURE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
  • FIGURE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2027
  • FIGURE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET DYNAMICS
  • FIGURE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
  • FIGURE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2027
  • FIGURE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, 2019-2027 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, 2019-2027 (USD MILLION)
  • FIGURE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, 2019-2027 (USD MILLION)
  • FIGURE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 17. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, 2019-2027 (USD MILLION)
  • FIGURE 18. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 19. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, 2019-2027 (USD MILLION)
  • FIGURE 20. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 21. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2019-2027 (USD MILLION)
  • FIGURE 22. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 23. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, 2019-2027 (USD MILLION)
  • FIGURE 24. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 25. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, 2019-2027 (USD MILLION)
  • FIGURE 26. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 27. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2021 VS 2027 (%)
  • FIGURE 28. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2021 VS 2027 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2027
  • FIGURE 30. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, 2019-2027 (USD MILLION)
  • FIGURE 31. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 32. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, 2019-2027 (USD MILLION)
  • FIGURE 33. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 34. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
  • FIGURE 35. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
  • FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2027
  • FIGURE 37. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, 2019-2027 (USD MILLION)
  • FIGURE 38. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 39. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., 2019-2027 (USD MILLION)
  • FIGURE 40. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 41. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, 2019-2027 (USD MILLION)
  • FIGURE 42. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 43. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, 2019-2027 (USD MILLION)
  • FIGURE 44. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 45. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, 2019-2027 (USD MILLION)
  • FIGURE 46. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 47. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, 2019-2027 (USD MILLION)
  • FIGURE 48. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 49. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, 2019-2027 (USD MILLION)
  • FIGURE 50. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 51. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 52. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 53. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 55. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 56. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 57. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 58. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 59. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 60. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
  • FIGURE 61. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
  • FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2027
  • FIGURE 63. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 64. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 65. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 67. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 68. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 69. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 70. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 71. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 72. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 73. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 74. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 75. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 76. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 77. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 78. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 79. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 80. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 81. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 82. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 83. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 84. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 85. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 86. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 87. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 88. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 89. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 90. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 91. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 92. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 93. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: FPNV POSITIONING MATRIX, 2021
  • FIGURE 94. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2021
  • FIGURE 95. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 7. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 8. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 9. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 10. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 12. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 13. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 14. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 15. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 17. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 18. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 19. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 20. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 21. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 22. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 23. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 24. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 25. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 26. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 27. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 28. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 30. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 31. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 32. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 33. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 35. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 36. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 37. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 38. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 40. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 41. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 42. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 43. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 45. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 46. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 47. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 48. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 49. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 52. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 53. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 54. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 57. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 58. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 59. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 60. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 63. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2019-2027 (USD MILLION)
  • TABLE 64. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 65. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY STATE, 2019-2027 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 68. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 69. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 70. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 73. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 74. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 75. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 78. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 79. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 80. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 83. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 84. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 85. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 88. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 89. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 90. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 93. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 94. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 95. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 96. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 97. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 98. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 99. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 100. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 101. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 102. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 103. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 104. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 105. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 106. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 107. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 108. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 109. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 110. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 111. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 112. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 113. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 114. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 115. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 116. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 117. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 118. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 124. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 125. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 126. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 127. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 128. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 129. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 130. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 131. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 132. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 133. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 134. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 135. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 136. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 137. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 138. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 139. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 140. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 141. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 142. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 143. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 144. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 145. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 146. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 147. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 148. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 149. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 150. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 151. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 152. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 153. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 154. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 155. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 156. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 157. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 158. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 159. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 160. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 161. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 162. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 163. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 164. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 165. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 166. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 167. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 173. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 174. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 175. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 176. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 177. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 178. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 179. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 180. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 181. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 182. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 183. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 184. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 185. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 186. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 187. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 188. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 189. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 190. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 191. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 192. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 193. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 194. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 195. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 196. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 205. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 206. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 207. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 208. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 209. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 210. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 211. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 212. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 213. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 214. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 215. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
  • TABLE 216. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 217. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
  • TABLE 218. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
  • TABLE 219. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
  • TABLE 220. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RANKING
  • TABLE 221. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2021
  • TABLE 222. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET MERGER & ACQUISITION
  • TABLE 223. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 224. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 225. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET INVESTMENT & FUNDING
  • TABLE 226. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 227. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET: LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!